É«¿Ø´«Ã½

Skip to Content
Resources

É«¿Ø´«Ã½ Comment Letter to FTC on Competition in Prescription Drug Markets

Comment Letter

Document Info

Published on Dec 8, 2017

Download and read the full Resource.

Related Issues
High-Price Drugs

Resource Details

On December 8, É«¿Ø´«Ã½ submitted comments to the Federal Trade Commission (FTC) for the official record of an FTC workshop held in early November on ways to promote greater competition in prescription drug markets—as a way to both reduce costs and improve access to drugs and treatments.